Liceall

Manufacturer
Bob Barker Company, Inc. | Chem-Tech Ltd.
Effective date
2021-07-23
Label type
HUMAN OTC DRUG LABEL
Version
4
Source
legacy-cache
Hydrated at
2026-08-01 22:39:40

Label at a glance#

ProductLiceall
Active ingredientPIPERONYL BUTOXIDE, PYRETHRUM EXTRACT
Label structure10 sections

Indications and uses

Treats head, pubic (crab) and body lice.

Dosage and administration

IMPORTANT: READ WARNINGS BEFORE USE Adults and children 2 years and over. Inspect – check each household member with a magnifying glass in bright light for lice/nits (eggs)-look for tiny nits near scalp, beginning at back of neck and behind ears – examine small sections of hair at a time – unlike dandruff which moves when touched, nits stick to the hair – if either lice or nits are found, treat with this product. ...

Label contents#

Full prescribing information#

PURPOSE:

OTC - PURPOSE SECTION

Liquid Lice Treatment for Human Use

USES:

INDICATIONS & USAGE SECTION

Treats head, pubic (crab) and body lice.

ACTIVE INGREDIENTS:

OTC - ACTIVE INGREDIENT SECTION

*Piperonyl Butoxide, Technical …3.0%

Pyrethrum Extract …… 0.3%

* Equivalent to min. 2.4% (butylcarbityl)(6-propylpiperonyl) ether and 0.6% related compounds.

TOTAL INGREDIENTS:

INACTIVE INGREDIENT SECTION

Water, Octylphenoxypoleethanol, Piperonyl Butoxide, Benzyl Alcohol, C13-14 Isoparaffin, Pyrethrum Extract.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

KEEP OUT OF THE REACH OF CHILDREN

WARNINGS:

WARNINGS SECTION

For external use only. Do not use - near eyes – inside nose, mouth or vagina – on lice in eyebrows or eyelashes. See a doctor if lice are present in these areas. Ask a doctor before use if you are – allergic to ragweed. May cause breathing difficulty or an asthmatic attack. When using this product – keep eyes tightly closed and protect eyes with washcloth or towel – if product gets in eyes flush with water right away – scalp itching or redness may occur. Stop use and ask a doctor if – breathing difficulty occurs – eye irritation occurs – skin or scalp irritation continues or infection occurs.
Do not freeze. Do not reuse original container.

DIRECTIONS:

DOSAGE & ADMINISTRATION SECTION

IMPORTANT: READ WARNINGS BEFORE USE

Adults and children 2 years and over.

Inspect – check each household member with a magnifying glass in bright light for lice/nits (eggs)-look for tiny nits near scalp, beginning at back of neck and behind ears – examine small sections of hair at a time – unlike dandruff which moves when touched, nits stick to the hair – if either lice or nits are found, treat with this product.

-SHAKE WELL BEFORE USING-

Treat – apply thoroughly to hair or other affected area. For head lice, first apply behind ears and to back of neck. Allow product to remain for 10 minutes, but no longer. Use warm water to form a lather, shampoo, then thoroughly rinse. For head lice, towel dry hair and comb out tangles.

Remove lice and their eggs (nits) – Use a fine-tooth or special lice/nit comb. Remove any remaining nits by hand (using a throw-away glove). Hair should remain slightly damp while removing nits - if hair dries during combing, dampen slightly with water - for head lice, part hair into sections. Do one section at a time starting on top of head. Longer hair may take 1 to 2 hours. - Lift a 1- to 2- inch wide strand of hair. Place comb as close to scalp as possible and comb with a firm, even motion away from scalp. - Pin back each strand of hair after combing - clean comb often. Wipe nits away with tissue and discard in a plastic bag. Seal bag and discard to prevent lice from coming back. - After combing, thoroughly recheck for lice/nits. Repeat combing if necessary. - Check daily for any lice/nits that you missed. - A second treatment must be done in 7 to 10 days to kill any newly hatched lice. - If infestation continues, see a doctor for other treatments. -

Children under 2 years ask a doctor.

OTHER INFORMATION:

OTC - WHEN USING SECTION

Head lice – lay small white eggs (nits) on hair shaft close to scalp. - Nits are most easily found on back of neck or behind ears. - Disinfect hats, hair ribbons, scarves, coats, towels and bed linens by machine washing in hot water [above 54º C (130º F)], then using hottest dryer cycle for at least 20 minutes. - Items that cannot be washed (bedspreads, blankets, pillows, stuffed toys, etc.) should be dry-cleaned or sealed in a plastic bag for 4 weeks, then removed outdoors and shaken out very hard before using again. - Items that cannot be washed, dry-cleaned or stored may be sprayed with a product designed for this purpose. - Soak all combs and brushes in hot water [above 54º C (130º F)] for at least 10 minutes. - Vacuum all carpets, mattresses, upholstered furniture, and car seats that may have been used by affected people.

Pubic (crab) lice – may be transmitted by sexual contact. Sexual partners should be treated simultaneously to avoid reinfestation. - Lice are very small and look like brown or gray dots on skin - usually cause intense itching and lay small white eggs (nits) on the hair shaft generally close to the skin surface - may be present on the short hairs of groin, thighs, trunk, and underarms, and occasionally on the beard and mustache. - Disinfect underwear by machine washing in hot water [above 54º C (130º F)], then using hottest dryer cycle for at least 20 minutes.

Body lice – body lice and their eggs (nits) are generally found in the seams of clothing, particularly in waistline and armpit area. - Body lice feed on skin then return to clothing to lay their eggs. - Disinfect clothing by machine washing in hot water [above 54º C (130º F)], then using hottest dryer cycle for at least 20 minutes. - Do not seal clothing in a plastic bag because nits can remain dormant for up to 30 days.

PRINCIPAL DISPLAY PANEL: 2 ounce bottle

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Liceall™
Liquid Lice Treatment for Human Use

KILLS

HEAD LICE (Pediculus Humanus capitis DeG)
BODY LICE (Pediculus Humanus Humanus L.)
PUBIC (CRAB) LICE (Phthirus pubis L.)
A NON-FOAMING SHAMPOO

ACTIVE INGREDIENTS:
    *Piperonyl Butoxide, Technical …3.0%
      Pyrethrum Extract …… 0.3%
TOTAL INGREDIENTS:
Water, Octylphenoxypolethoxyethanol, Piperonyl Butoxide, Benzyl Alcohol, C13-14 Isoparaffin, Pyrethrum extract.
* Equivalent to min. 2.4% (butylcarbityl)(6-propylpiperonyl) ether and 0.6% related compounds.
KEEP OUT OF THE REACH OF CHILDREN
CAUTION
CONTENTS: 2 fl. oz. (59 ml)

Distributed By: Bob Barker Company, Inc.
134 North Main St., Fuquay-Varina, N.C. 27526

Liceall2ozLiceall2oz

PRINCIPAL DISPLAY PANEL: 1 Gallon Jug

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Liceall™
Liquid Lice Treatment for Human Use

KILLS

HEAD LICE
(Pediculus Humanus capitis DeG)
BODY LICE
(Pediculus Humanus Humanus L.)
PUBIC (CRAB) LICE
(Phthirus pubis L.)

A NON-FOAMING SHAMPOO

ACTIVE INGREDIENTS:
    *Piperonyl Butoxide, Technical …3.0%
      Pyrethrum Extract …… 0.3%
TOTAL INGREDIENTS:
Water, Octylphenoxypolethoxyethanol, Piperonyl Butoxide, Benzyl Alcohol, C13-14 Isoparaffin, Pyrethrum extract.
* Equivalent to min. 2.4% (butylcarbityl)(6-propylpiperonyl) ether and 0.6% related compounds.

KEEP OUT OF THE REACH OF CHILDREN
CAUTION

SEE OTHER PRECAUTIONS ON SIDE PANEL.

CONTENTS: 1 GALLON (3.785 Liters)

DISTRIBUTED BY:
BOB BARKER COMPANY, INC.
134 North Main St.
Fuquay-Varina, N.C. 27526

LiceallGalLiceallGal

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
PIPERONYL BUTOXIDEACTIVE INGREDIENTLWK91TU9AH1
PYRETHRUM EXTRACTACTIVE INGREDIENTZUM06L90GV1
PIPERONYL BUTOXIDEACTIVE MOIETYLWK91TU9AH1
PYRETHRUM EXTRACTACTIVE MOIETYZUM06L90GV1
BENZYL ALCOHOLINACTIVE INGREDIENTLKG8494WBH1
C13-14 ISOPARAFFININACTIVE INGREDIENTE4F12ROE701
OCTOXYNOL-9INACTIVE INGREDIENT7JPC6Y25QS1
WATERINACTIVE INGREDIENT059QF0KO0R1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 8 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
53247-33053247-330-02, 53247-330-40

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 6 matching rows.

Source Document#

Source XML · Source PDF

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 53 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHINJECTION, SOLUTION / INTRA-ARTICULAR23 mgExact identifier — unii candidate
50 equally ranked IID candidates
OCTOXYNOL-9OCTOXYNOL-97JPC6Y25QSGEL / TOPICAL2 mgExact identifier — unii candidate
3 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHINJECTION / SOFT TISSUE23 mgExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHINJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR144 mgExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHSUSPENSION / AURICULAR (OTIC)0.9 %w/vExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHINJECTION, SOLUTION / INTRAVENOUS400 mgExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHSPRAY, METERED / NASAL5 mg/1mlExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHLIQUID / INTRAVENOUS1.04 %w/vExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHINJECTION / INTRA-ARTERIAL0.9 %w/vExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRACAVERNOUS18 mgExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHINJECTION / SUBCONJUNCTIVAL252 mgExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHINJECTION, SUSPENSION / INTRASYNOVIAL18 mgExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHCREAM / VAGINAL1 %w/wExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHGEL / RECTAL124 mgExact identifier — unii candidate
50 equally ranked IID candidates
OCTOXYNOL-9OCTOXYNOL-97JPC6Y25QSLOTION / TOPICAL5 mgExact identifier — unii candidate
3 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHINJECTION / ENDOTRACHEAL54 mgExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHINJECTION / SUBCUTANEOUS90 mgExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHINJECTION, POWDER, FOR SOLUTION / INTRAVENOUS144 mgExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHLOTION / TOPICAL4000 mgExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRACAVITARY8.4 mgExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHSOLUTION / ORAL360 mgExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHINJECTION, EMULSION / SUBCUTANEOUS225 mgExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHINJECTION, SUSPENSION / INTRALESIONAL20 mgExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHINJECTION, SUSPENSION / INTRA-ARTICULAR40 mgExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHSUSPENSION / ORAL100 mgExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHSUSPENSION / TOPICAL1 %w/wExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHSOLUTION / INTRAVENOUS242 mgExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHSHAMPOO / TOPICAL1.25 %w/wExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHINJECTION / INTRALESIONAL23 mgExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHOINTMENT / TOPICAL2.2 %w/wExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHINJECTION / INTRA-ARTICULAR1 %w/vExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHGEL / TOPICAL185 mgExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHCREAM / TOPICAL160 mgExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHCAPSULE / ORAL450 mgExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHINJECTION, SOLUTION / INTRAMUSCULAR500 mgExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHINJECTION, SOLUTION / SUBCUTANEOUS0.95 %w/vExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHINJECTION / INTRAVENOUS1620 mgExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHINJECTION, SUSPENSION / SOFT TISSUE40 mgExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHTABLET / ORAL1.06 mgExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHTABLET, DELAYED RELEASE / ORAL2.31 mgExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHINJECTION, EMULSION / INTRAMUSCULAR225 mgExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHINJECTION, EMULSION / INTRAVENOUS45 mgExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHINJECTION / INTRACAVITARY0.01 mlExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHSUPPOSITORY / RECTAL129 mgExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHINJECTION / INTRAMUSCULAR1000 mgExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHSPRAY / NASAL5 mgExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHGEL / VAGINAL100 mgExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHSOLUTION / TOPICAL2 %w/wExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHSUPPOSITORY / VAGINALNAExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHSOLUTION / INTRAMUSCULAR54 mgExact identifier — unii candidate
50 equally ranked IID candidates
OCTOXYNOL-9OCTOXYNOL-97JPC6Y25QSSPONGE / TOPICAL5 %w/wExact identifier — unii candidate
3 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHINJECTION, SUSPENSION / INTRAMUSCULAR40 mgExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHCAPSULE, EXTENDED RELEASE / ORAL1.23 mgExact identifier — unii candidate
50 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
69a912e2-33cd-4331-9709-cf7c3ca143c2ef176ed9-3c14-45ec-a46f-4adc378d407f2023-10-31WarningsExact identifier
spl set id: ef176ed9-3c14-45ec-a46f-4adc378d407f

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.